Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Immunoglobulin superfamily DCC subclass member 3 pseudogene (ENSG00000231827, also known as LOC343052) is a genomic element in humans annotated as a pseudogene, which means it closely resembles a protein-coding gene but harbors disabling mutations and does not produce a functional protein[1][3][4][7][9]. Pseudogenes may be transcribed at low levels and can generate non-coding RNAs that occasionally have regulatory effects, including modulation of gene expression or chromatin state[2][10]. As a pseudogene, this locus has no established role as a receptor, enzyme, or drug target, and its biological function (if any) is limited to possible RNA-mediated regulatory effects that are rare, tissue-specific, and not well characterized for this gene[2][4][5]. No disease associations, drug interactions, or clinical biomarkers are reported for this entity.
None established for drugs (see "interacting_drugs")[1][5][9]. Some pseudogenes may modulate gene expression via regulatory RNAs, but there are no drugs targeting this mechanism here[2][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin superfamily DCC subclass member 3 pseudogene (IGDCC3 pseudogene).